Skip to main content

House Bill

H.R. 2213

119th Congress

Medical Supply Chain Resiliency Act

In Committee
Introduced:Jul 29, 2025

Primary Sponsor

Michael T. McCaul

Michael T. McCaul

Representative

Republican
TX-10

Cosponsors

5

Quick Stats

Policy Area

Environmental Protection

Summary

The Medical Supply Chain Resiliency Act would limit funding for the Agency of Toxic Substances and Disease Registry, which monitors and investigates environmental health issues. This could reduce the agency's ability to study and address toxic substance risks that could impact public health.

Latest Action

Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.

SponsorMichael T. McCaul (R-TX)
Introduced7/29/2025
StatusReferred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period
ChamberHouse
Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Medical Supply Chain Resiliency Act

The Medical Supply Chain Resiliency Act would limit funding for the Agency of Toxic Substances and Disease Registry, which monitors and investigates environmental health issues. This could reduce the agency's ability to study and address toxic substance risks

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The Medical Supply Chain Resiliency Act would limit funding for the Agency of Toxic Substances and Disease Registry, which monitors and investigates environmental health issues. This could reduce the agency's ability to study and address toxic substance risks that could impact public health.

Bill Number
2213
Sponsor
Michael T. McCaul (R-TX)
Introduced
7/29/2025
Status
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period
Policy Area
Environmental Protection

Data from Congress.gov

AI-generated summary

Fact Sheet

Title
Medical Supply Chain Resiliency Act
Bill Number
2213
Sponsor
Michael T. McCaul (R-TX)
Status
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period
Introduced
7/29/2025
Summary
The Medical Supply Chain Resiliency Act would limit funding for the Agency of Toxic Substances and Disease Registry, which monitors and investigates environmental health issues. This could reduce the agency's ability to study and address toxic substance risks that could impact public health.

Data from Congress.gov

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.